Validation and further development of the WHO 10-year fracture risk assessment tool in Italian postmenopausal women: Project rationale and description

Clinical and Experimental Rheumatology

Volumn 28, Issue 4, 2010, Pages 561-570

  Adami, Silvano ^a   Bianchi, Gerolamo ^b   Brandi, Maria Luisa ^c   Di Munno, Ombretta ^d   Freudiani, Bruno ^e   Gatti, Davide ^a   Giannini, Sandro ^f   Girasole, Giuseppe ^b   Minisola, Giovanni ^g   Minisola, Salvatore ^h   Nuti, Ranuccio ^e   Pedrazzoni, Mario ⁱ   Rossini, Maurizio ^a   Varenna, Massimo ^j  

^a UNIVERSITY OF VERONA   (Italy)

^b Rheumatology Unit   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF PISA   (Italy)

^e UNIVERSITY OF SIENA   (Italy)

^f UNIVERSITY OF PADOVA   (Italy)

^g SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^h SAPIENZA UNIVERSITY OF ROME   (Italy)

ⁱ UNIVERSITY OF PARMA   (Italy)

^j ISTITUTO ORTOPEDICO GAETANO PINI   (Italy)

more..

Author keywords

Defra; Fracture risk; Fragility fractures; Frax ; Osteoporosis; Osteoporosis treatment threshold

Indexed keywords

AGED; ALGORITHM; ETHNOLOGY; FRACTURE; HUMAN; ITALY; MIDDLE AGED; POSTMENOPAUSE OSTEOPOROSIS; PREDICTIVE VALUE; REPRODUCIBILITY; REVIEW; RISK ASSESSMENT; WORLD HEALTH ORGANIZATION;

AGED; AGED, 80 AND OVER; ALGORITHMS; FRACTURES, BONE; HUMANS; ITALY; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; WORLD HEALTH ORGANIZATION;

EID: 79952054235     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. CUMMINGS S R, MELTON L J III. Epidemiology and outcomes of osteoporotic fractures. Lancet 2002; 359: 1761-67.
2. ROSSINI M, ALBERTI V, FLOR L, MASIERO L, GIANNINI S, ADAMI S. Effect of oral vitamin D2 yearly bolus on hip fracture risk in elderly women a community primary prevention study. Aging Clin Exp Res 2004; 16: 432-6.
3. NATIONAL OSTEOPOROSIS FOUNDATION Physician's Guide to Prevention and Treatment of Osteoporosis. Washington DC National Osteoporosis Foundation; 2008. www.nof. org/physguide.
4. BLACK DM, STEINBUCH M, PALERMO L et al. An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int 2001; 12: 519-28.
5. PLUIJM SMF, KOES B, Delaet C et al. A simple risk score for the assessment of absolute fracture risk in general practice based on two longitudinal studies. J Bone Miner Res 2009; 24: 768-74.
6. NGUYEN ND, FROST SA, CENTER JR, EISMAN JA, NGUYEN TV. Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks. Osteoporos Int 2008; 19: 1431-44.
7. ROBBINS J, ARAGAKI AAK, KOOPERBERG C et al. Factors associated with 5-year risk of hip fracture in postmenopausal women. JAMA 2007; 298: 2389-98.
8. LESLIE WD, TSANG JF, LIX LM. Simplified system for absolute fracture risk assessment clinical validation in Canadian women. J Bone Miner Res 2009; 24: 353-60.
9. WORLD HEALTH ORGANIZATION 2008 FRAX WHO FRACTURE RISK ASSESSMENT TOOL Available at www.shef.ac.uk/FRAX/index. htm. Accessed May 5, 2008.
10. KANIS JA, ODEN A, JOHANSSON H, BORGSTROM F, STROM O, MCCLOSKEY E. FRAX® and its application to clinical practice. Bone 2009; 44: 732-43.
11. KANIS JA, ODEN A, JOHNELL O et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 2007; 18: 1033-46.
12. KANIS JA, BORGSTROM F, Delaet C et al. Assessment of fracture risk. Osteoporos Int 2005; 16: 581-9.
13. Donaldson MG, Cawthon PM, Lui LY et al. Estimates of the proportion of older white women who would be recommended for pharmacologic treatment by the New U.S. National Osteoporosis Foundation Guidelines. J Bone Min Res 2009; 24: 675-80.
14. RD et al. National Osteoporosis Foundation Guide Committee. Osteoporos Int 2008; 19: 449-58.
15. RIBOT C, TEMOLLIERES F, POUILLES JM. Can we detect women with low bone mass using clinical risk factors? Am J Med 1995; 98: 52S-55S.
16. MCCLUNG MR, GEUSENS P, MILLER PD et al. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med 2001; 344: 333-40.
17. HAMDY RC, KIEBZAK GM. Variance in 10-year fracture irsk calculated with and without T-scores in select subgroups of normal and osteoporotic patients. J Clin Densitom 2009; 12: 158-61.
18. PONGCHAIYAKUL C, NGUYEN ND, JONES G. Asymptomatic vertebral deformity as a major risk factor for subsequent fractures and mortality a long-term prospective study. J Bone Miner Res 2005; 20: 1349-55.
19. KLOTZBUECHER CM, ROSS PD, LANDSMAN P, ABBOTT TAI, BERGER M. Patients with prior fractures have an increased risk of future fractures:a summary of the literature and statistical synthesis. J Bone Miner Res 2000; 15: 721-39.
20. VAN GEEL TA, VAN HELDEN S, GEUSENS PP, WINKENS B, DINANT GJ. Clinical subsequent fractures cluster in time after first fractures. Ann Rheum Dis 2009; 68: 99-102.
21. VAN STAA TP. The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis. Calcif Tissue Int (2006); 79: 129-37.
22. HUOPIO J, KRÖGER H, HONKANEN R, SAARIKOSKI S, ALHAVA E. Risk factors for perimenopausal fractures a prospective study. Osteoporos Int 2000; 11: 219-27.
23. KANIS JA, JOHNELL EO. ODEN AE, DELAET C, DeTerlizzi F, Delaet Ten-year probabilities of clinical vertebral fractures according to phalangeal quantitative ultrasonography. Osteoporos Int 2005; 16: 1065-70.
24. ESPALLARGUES M, SAMPIRETRO-COLOM L, ESTRADA MD et al. Identifying bone-massrelated risk factors for fracture to guide bone densitometry measurements: a systematic review of the literature. Osteoporos Int 2001; 12: 811-22.
25. GENANT HK, COOPER C, POOR G et al. Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int 1999; 10: 259-64.
26. CUMMINGS SR, NEVITT MC, BROWNER WS et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1995; 332: 767-73.
27. KANIS JA, JOHNELL O, DELAET C et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone 2004; 35: 375-82.
28. ROSS PD, DAVIS JW, EPSTEIN RS, WASNICH RD. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 1991; 114: 919-23.
29. BLACK DM, ARDEN NK, PALARMO L, PEARSON J, CUMMINGS SR. Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. J Bone Miner Res 1999; 14: 821-8.
30. ISMAIL AA, COCKERILL W, COOPER C et al. Prevalent vertebral deformity predicts incident hip though not distal forearm fracture results from the European prospective osteoporosis. Osteoporos Int 2001; 12: 85-90.
31. HASSERIUS R, JOHNELL O, NILSSON BE et al. Hip fracture patients have more vertebral deformities than subjects in population-based studies. Bone 2003; 32: 180-4.
32. DAVIS JW, GROVE JS, WASNICH RD, ROSS PD. Spatial relationships between prevalent and incident spine fractures. Bone 1999; 24: 261-4.
33. NEVITT MC, ROSS PD, PALERMO L, MUSLINER T, GENANT HK, THOMPSON DE. Association of prevalent vertebral fractures, bone density, and alendronate treatment with incident vertebral fractures effect of number and spinal location of fractures. The Fracture Intervention Trial Research Group. Bone 1999; 25: 613-9.
34. KANIS JA, JOHNELL O, ODEN A, JOHANSSON H, MCCLOSKEY E. FRAX® and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008; 19: 385-97.
35. KANIS JA, JOHANSSON H, ODEN A et al. A family history of fracture and fracture risk a meta-analysis. Bone 2004; 35: 1029-37.
36. LAFLEUR J, MCADAM-MARX C, KIRKNESS C, BRIXNER DI. Clinical Risk Factors for Fracture in Postmenopausal Osteoporotic Women A Review of the Recent Literature. Ann Pharmacother 2008; 42: 375-86.
37. KANIS JA, JOHNELL O, ODEN A et al. Smoking and fracture risk a meta-analysis. Osteoporos Int 2005; 16: 155-62.
38. VESTERGAARD P, MOSEKILDE L. Fracture risk associated with smoking a meta-analysis. J Intern Med 2003; 254: 572-83.
39. CHAKKALAKAL DA. Alcohol-induced bone loss and deficient bone repair. Alcohol Clin Exp Res 2005; 29: 2077-90.
40. KANIS JA, JOHANSSON H, JOHNELL O et al. Alcohol intake as a risk factor for fracture. Osteoporos Int 2005; 16: 737-42.
41. BERG KM, KUNINS HV, JACKSON JL et al. Association between alcohol consumption and both osteoporotic fracture and bone density. Am J Med 2008; 121: 406-18.
42. DARGENT-MOLINA P, SCHOTT AM, HANS D, FAVIER F et al. Separate and combined value of bone mass and gait speed measurements in screening for hip fracture risk:results from the EPIDOS study. Osteoporos Int 1999; 9: 188-92.
43. SALKELD G, CAMERON ID, CUMMING RG et al. Quality of life related to fear of falling and hip fracture in older women a time trade off study. BMJ 2000; 320: 341-6.
44. O'LOUGHLIN J ROBITAILLE Y, BOIVIN JF, SUISSA S. Incidence of and risk factors for falls and injurious falls among the community-dwelling elderly. Am J Epidemiol 1993; 137: 342-54.
45. TINETTI ME. Factors associated with serious injury during falls by ambulatory nursing home residents. J Am Geriatr Soc 1987; 35: 644-8.
46. NATIONAL OSTEOPOROSIS FOUNDATION Physician's Guide to Prevention and Treatment of Osteoporosis. Washington DC National Osteoporosis Foundation; 2008. www.nof. org/physguide.
47. NICE The assessment and prevention of falls in older people. Clinical practice guideline 2004.
48. VAN STAA TP, LEUFKENS HGM, ABENHAIM L, ZHANG B, COOPER C. Oral corticosteroids risk relationship to daily and cumulative doses. Rheumatology 2000; 39: 1383-9.
49. VAN STAA, TP, GEUSENS P, BIJLSMA JWJ, LEUFKENS HGM, COOPER C. Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 2006; 54: 3104-12.
50. VAN STAA TP, LEUFKENS HG, COOPER C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 2002; 13: 777-87.
51. KANIS JA, JOHANSSON H, ODEN A et al. A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 2004; 19: 893-9.
52. Vanstaa TP, Leufkens HGM, ABENHAIM L, ZHANG B, COOPER C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res 2000; 15: 993-1000.
53. NAGANATHAN V, JONES G, NASH P, NICHOLSON G, EISMAN J, SAMBROOK PN. Vertebral fracture risk with long-term corticosteroid therapy prevalence and relation to age, bone density, and corticosteroid use. Arch Intern Med 2000; 160: 2917-22.
54. ADAMI S. L'Osteoporosi cortisonica. Reumatismo 2000; 1: 52-77.
55. VESTERGAARD P, REJNMARK L, MOSEKILDE L. Fracture risk associated with systemic and topical corticosteroids. J Intern Med 2005; 257: 374-84.
56. HOOYMAN JR, MELTON LJ, NELSON AM et al. Fractures after rheumatoid arthritis a population-based study. Arthritis Rheum 1984; 27: 1353-61.
57. ØRSTAVIK, RAGNHILD E, HAUGEBERG G et al. Vertebral deformities in rheumatoid arthritis: a comparison with population-based controls. Arch Intern Med 2004; 164. 420-5.
58. VAN STAA TP, GEUSENS P, BIJLSMA JW, LEUFKENS HG, COOPER C. Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 2006; 54: 3104-12.
59. KANIS JA, on behalf of the WORLD HEALTH ORGANISATION SCIENTIFIC GROUP 2007 Assessment of osteoporosis at the primary health care level. WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK.
60. KANIS JA, ODEN A, JOHNELL O et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 2007; 18: 1033-46.
61. KANIS JA, BORGSTROM F, DELAET C et al. Assessment of fracture risk. Osteoporos Int 2005; 16: 581-9.
62. SINIGAGLIA L, VARENNA M, GIRASOLE G, BIANCHI G. Epidemiology of Osteoporosis in Rheumatic Diseases. Rheum Dis Clin N Am 2006; 32: 631-58.
63. GRANA J, MAHIA IV, MEIZOSO MO, VAZQUEZ T. Multiple osteonecrosis of the jaw, oral bisphosphonate therapy and refractory rheumatoid arthritis (Pathological fracture associated with ONJ and BP use for osteoporosis). Clin Exp Rheumatol 2008; 26: 384-5.
64. BULTINK I E M, LEMS WF, KOSTENSE PJ, DIJKMANS BAC, VOSKUYL AE. Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum 2005; 52: 2044-50.
65. YEE CS, CRABTREE N, SKAN J et al. Prevalence and predictors of fragility fractures in systemic lupus erythematosus. Ann Rheum Dis 2005; 64: 111-3.
66. RAMSEY-GOLDMAN R, DUNN JE, HUANG CF et al. Frequency of fractures in women with systemic lupus erythematosus: comparison with United States population data. Arthritis Rheum 1999; 42: 882-90.
67. BORBA VZ, MATOS PG, DaSilva Viana PR, FERNANDEZ A, SATO EI, LAZARETTICASTRO M. High prevalence of vertebral deformity in premenopausal systemic lupus erythematosus patients. Lupus 2005; 14: 529-33.
68. GRATACOS J, COLLADO A, PONS F et al. Significant loss of bone mass in patients with early, active ankylosing spondylitis. Arthritis Rheum 1999; 42: 2319-24.
69. MAILLEFERT JF, AHO LS, EL MAGHRAOUI A et al. Changes in bone density in patients with ankylosing spondylitis: a two-year follow-up study. Osteoporos Int 2001; 12: 605-9.
70. COOPER C, CARBONE L, MICHET CJ et al. Fracture risk in patients with ankylosing spondylitis: a population based study. J Rheumatol 1994; 21: 1877-82.
71. VOSSE D, LANDEWÉ R, VAN DER HEIJDE D, VAN DER LINDEN S, VAN STAA TP, GEUSENS P. Ankylosing spondylitis and the risk of fracture: results from a large primary carebased nested case control study .Ann Rheum Dis 2009; 68: 1839-42.
72. GHOZLANI I, GHAZI M, NOUIJAI A et al. Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis. Bone 2009; 44: 772-6.
73. YUEN SY, ROCHWERG B, OUIMET J, POPE JE. Patients with scleroderma may have increased risk of osteoporosis. A comparison to rheumatoid arthritis and noninflammatory musculoskeletal conditions. J Rheumatol 2008; 35: 1073-8.
74. HARRISON BJ, HUTCHINSON CE, ADAMS J et al. Assessing periarticular bone mineral density in patients with early psoriatic arthritis or rheumatoid arthritis. Ann Rheum Dis 2002; 61: 1007-11.
75. NOLLA JM, ROZADILLA A, GOMEZ-VAQUERO C et al. Bone mineral density in patients with peripheral psoriatic arthritis. Rev Rhum Engl Ed 1999; 66: 457-61.
76. FREDIANI B, ALLEGRI A, FALSETTI P et al. Bone mineral density in patients with psoriatic arthritis. J Rheumatol 2001; 28: 138-43.
77. DEL RIO L, PERIS P, JOVER L, GUAÑABENS N, MONEGAL A, DIGREGORIO S. Men suffer vertebral fractures with similar spinal T-scores than women. Clin Exp Rheumatol 2008; 26: 283-7.
78. TENG GG, CURTIS JR, SAAG KG. Mortality and osteoporotic fractures: is the link causal, and is it modifiable? Clin Exp Rheumatol 2008; 26 (Suppl. 51o): S125-37.
79. Adami S, Viapiana O, Gatti D, Idolazzi L, Rossini M. Relationship between serum parathyroid hormone, vitamin D sufficiency, age, and calcium intake. Bone 2008; 42: 267-70.